Results of a single-center retrospective study revealed that patients with darker pigmented skin frequently experienced irCAEs, therefore, increased surveillance is needed in SOC patients.
A patient education and monitoring program improved patients’ ability to manage and report adverse events related to treatment with ICIs.
Using remote communications technology, a major cancer center was able to manage symptoms in high-risk patients initiating treatment at a regional location.
Although the CMS OCM model requires that patients have 24/7 access to outpatient clinics and telephone/secure messaging with a clinician, most patients who presented to the ED did not use these services in the 24 hours prior to an ED visit.
SARP, a novel wearable monitoring platform, gave clinicians a supplementary opportunity to monitor patient health and assess risk in patients of advanced age undergoing treatment for cancer.
Review of responses to clinical trial prompts within an oncology clinical pathways system identified barriers to increasing patient enrollment in clinical trials.
Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.
A combination of pembrolizumab and an antibody-drug conjugate demonstrated a 73% overall response rate in a phase 1/2 clinical trial.
Age, BMI, and education may indicate physical activity levels in men seeking genetic counseling and/or testing for prostate cancer.
Assessments and interventions for younger and female patients with RCC may need to be targeted, as these patients may have a greater fear of disease recurrence.
